AI test aims to predict breast Cancer's response to chemo
NCT ID NCT07327970
Summary
This study is testing a new AI tool called Ataraxis that analyzes breast cancer biopsy images and patient information to predict how well chemotherapy will work before surgery. It aims to see if this tool can be easily used in real hospitals and if its predictions match what actually happens after treatment. The study involves 150 adults with early-stage breast cancer who are already planning to receive chemotherapy before surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.